News

Fortis Malar Hospitals Limited submitted certificates to the BSE Limited on October 8, 2026, detailing securities dematerialized and rematerialized for the quarter ended September 30, 2026, as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018; Kfin Technologies Limited, formerly known as KFin Technologies Private Limited, served as the Registrar and Transfer Agent for Fortis Malar Hospitals Limited and furnished the information to the stock exchanges.

Fortis Malar Hospitals Limited will close its trading window for share transactions from October 1, 2026, until 48 hours after the declaration of its unaudited financial results for the quarter and half year ended September 30, 2026, as per its policy for prevention of insider trading, the company said in a filing to the BSE Limited.

Net profit of Fortis Malar Hospitals declined 96.39% to Rs 0.15 crore in the quarter ended June 2026 as against Rs 4.15 crore during the previous quarter ended June 2025. There were no Sales reported in the quarter ended June 2026 as against Rs 0.02 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales00.02 -100 OPM %0-1650.00 - PBDT0.204.28 -95 PBT0.204.28 -95 NP0.154.15 -96 Powered by Capital Market - Live News

Fortis Malar Hospitals will hold a meeting of the Board of Directors of the Company on 4 August 2026.

Fortis Malar Hospitals announced that the 35th Annual General Meeting(AGM) of the company will be held on 29 July 2026.